A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications

February 6, 2014 updated by: Garbis Dabaghian, Northwell Health

A Geriatric Home Visit Program to Reduce Post Hip Fracture Morbidity and Mortality

The overall goal of the project is to reduce the incidence of post hip fracture morbidity and mortality by conducting geriatric fellow periodic home visits.The assessment will be multidisciplinary and will include assessments of functional status, depression, environmental risks and medical conditions. This group will be compared against a group followed by the usual standard of care post hip fracture.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

All patients post hip fracture on the hospital's rehabilitation service that will be discharged to home will be enrolled after obtaining consent. Patients will be randomized into the intervention group and the usual standard of care group.We will be recruiting a total of 100 patients , with equal numbers for each group.All patients will undergo an initial assessment by a Geriatric fellow prior to discharge . The intervention group will be seen at the time of discharge in the hospital and at home at 1, 3, and 6 months post hip fracture. The control group will be seen at the time of discharge in the hospital and then again at 6 months for follow up. The two groups will then be compared for multiple known complications post hip fractures well as mortality.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Staten Island, New York, United States, 10305
        • Staten Island University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All post hip fracture patients on the hospital's rehabilitation service being discharged to home .

Exclusion Criteria:

  • Patients discharged to nursing homes or rehabilitation facilities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No intervention
Standard of care with no home visit
Experimental: Home Visit
After the post hip-fracture patient is discharged to home, there will be home visits by a geriatric fellow assess overall function and response to treatment/s by depression screen, FIM scores, and environmental risk assessment
Other: Home Visit
A geriatric fellow will conduct a comprehensive in hospital post discharge assessment of hip fracture patients discharged to home in the intervention group.Follow up home visits will occur at 1,3 and 6 months post discharge.Any problems will be referred to the patient's primary care physician.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decreased rate of depression, falls, medication errors and post-op-complications
Time Frame: 6 months and 1 year
geriatric depression screen, FIM score, medication reconciliation
6 months and 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
environmental hazards will be identified
Time Frame: 6 months and 1 year
safety inspection of home
6 months and 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Northwell Health

Collaborators

Staten Island University Hospital

Investigators

  • Principal Investigator: Mark Jarrett, M.D., Staten Island University Hospital
  • Study Director: Marianne Smith, M.D., Staten Island University Hospital
  • Principal Investigator: Garbis Dabagian, M.D., Staten Island University Hospital
  • Principal Investigator: Donna Seminara, M.D., Staten Island University Hospital
  • Principal Investigator: Jeffery Weinberg, M.D., Staten Island University Hospital
  • Principal Investigator: Mario Castellanos, M.D., Staten Island University Hospital
  • Principal Investigator: Anita Szerszen, M.D., Staten Island University Hospitial

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2008

Primary Completion (Actual)

February 1, 2011

Study Completion (Actual)

February 1, 2011

Study Registration Dates

First Submitted

October 25, 2012

First Submitted That Met QC Criteria

February 6, 2014

First Posted (Estimate)

February 10, 2014

Study Record Updates

Last Update Posted (Estimate)

February 10, 2014

Last Update Submitted That Met QC Criteria

February 6, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 08-023

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Home Visit

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe